1000793-42-9 Usage
Molecular structure
2-(6-Bromo-2H-benzo[b][1,4]oxazin-4(3H)-yl)-6,6-dimethyl-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)-one has a complex molecular structure with multiple aromatic rings and heteroatoms.
Aromatic rings
The compound contains three aromatic rings a benzene ring in the benzo[b][1,4]oxazin moiety, a pyridine ring in the pyridin-4-one moiety, and a partially unsaturated ring in the thiazolo moiety.
Heteratoms
The compound includes a bromine atom, oxygen atoms in the oxazin ring, and sulfur atoms in the thiazolo ring.
Biological and pharmacological activities
The presence of multiple aromatic rings and heteroatoms suggests that the compound may have potential biological and pharmacological activities.
Handling precautions
It is important to handle this compound with caution due to its complex structure and potential biological activities.
Property determination
The properties and potential uses of the compound should be determined through thorough chemical analysis and testing.
Specific functional groups
The compound contains a bromine atom in the 6-position of the benzo[b][1,4]oxazin moiety, a 6,6-dimethyl group in the 6,7-dihydrothiazolo moiety, and a pyridin-4-one moiety.
Check Digit Verification of cas no
The CAS Registry Mumber 1000793-42-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,0,7,9 and 3 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1000793-42:
(9*1)+(8*0)+(7*0)+(6*0)+(5*7)+(4*9)+(3*3)+(2*4)+(1*2)=99
99 % 10 = 9
So 1000793-42-9 is a valid CAS Registry Number.
1000793-42-9Relevant articles and documents
Achieving multi-isoform PI3K inhibition in a series of substituted 3,4-dihydro-2H-benzo[1,4]oxazines
Perry, Benjamin,Alexander, Rikki,Bennett, Gavin,Buckley, George,Ceska, Tom,Crabbe, Tom,Dale, Verity,Gowers, Lewis,Horsley, Helen,James, Lynwen,Jenkins, Kerry,Crepy, Karen,Kulisa, Claire,Lightfoot, Helen,Lock, Chris,Mack, Stephen,Morgan, Trevor,Nicolas, Anne-Lise,Pitt, Will,Sabin, Verity,Wright, Sara
, p. 4700 - 4704 (2008)
The SAR and pharmacokinetic profiles of a series of multi-isoform PI3K inhibitors based on a 3,4-dihydro-2H-benzo[1,4]oxazine scaffold are disclosed.
PI3 KINASE INHIBITORS AND USES THEREOF
-
, (2011/10/10)
The present invention provides compounds, compositions thereof, and methods of using the same.
PYRROLOTHIAZOLES AS PI3-KINASE INHIBITORS
-
Page/Page column 73-74, (2009/07/17)
A series of 4,5-dihydro-6H-pyrrolo[3,4-d][1,3]thiazol-6-one derivatives, and analogues thereof, which are substituted in the 2-position by an optionally substituted morpholin-4-yl moiety, being selective inhibitors of PI3 kinase enzymes, are accordingly o
